Lantern Pharma 
Welcome,         Profile    Billing    Logout  
  Products    Diseases    Products    Trials    News 

Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials
 036912151821242730
            
            
             
irofulven-1 (LP-100) / Lantern Pharma, Eisai           
          
            
             
Tavocept (dimesna) / BioNumerik, Lantern Pharma           
          
            
             
LP-284 / Lantern Pharma           
          
            
             
TTC-352 / TTC Oncology, Lantern Pharma           
          
            
             
hydroxyureamethylacylfulvene (STAR-001) / Lantern Pharma